All Articles In 'Tag Archives: 'Pharma''

Comparative Effectiveness Research: How Agency for Healthcare Research and Quality Spent $474 Million in ARRA Funds

Comparative Effectiveness Research: How Agency for Healthcare Research and Quality Spent $474 Million in ARRA Funds

As part of the $1.1 billion provided to the Department of Health and Human Services (HHS) earmarked for comparative effectiveness research (CER) under the American Recovery and Reinvestment Act (ARRA or Recovery Act) of 2009, $474 [...]

Prescription Drug Pricing: Estimating Generic Drug Cost Savings

Prescription Drug Pricing: Estimating Generic Drug Cost Savings

Prescription drug spending rose by $135 billion between 2001 and 2010 to comprise approximately 12 percent of the nation’s overall healthcare outlay. While drug expenditure was one of the fastest growing components of U.S. healthcare spending [...]

Electronic Prescribing: Benefits and Challenges of E-Prescribing

Electronic Prescribing: Benefits and Challenges of E-Prescribing

A study funded by AHRQ and published in the Journal of the American Medical Informatics Association, Transmitting and processing electronic prescriptions: Experiences of physician practices and pharmacies, identifies both the benefits and challenges with electronic prescribing [...]

PCORI Identifies Five National Priorities for Comparative Clinical Effectiveness Research

PCORI Identifies Five National Priorities for Comparative Clinical Effectiveness Research

The Patient-Centered Outcomes Research Institute (PCORI) has published its first set of proposed national priorities for research, Draft National Priorities for Research and Research Agenda Version 1. This 22-page publication highlights five focus areas for use [...]

Direct-to-Consumer Advertising of Prescription Drugs: Legal, Policy, Market, and Public Health Issues for Potential Bans on DTC Advertising of New Brand Drugs

Direct-to-Consumer Advertising of Prescription Drugs: Legal, Policy, Market, and Public Health Issues for Potential Bans on DTC Advertising of New Brand Drugs

Direct-to-Consumer (DTC) advertising of prescription drugs, especially new brand-named drugs, remains controversial.  Some in Congress remain eager to prohibit advertising of brand-name prescription drugs to consumers in the first two years following a drug’s approval by [...]